Oral etoposide has considerable activity in small cell lung cancer and
the low risk of toxicity has resulted in the frequent prescription of
this agent in elderly or infirmed patients, We describe a case of fat
al pulmonary toxicity following the administration of oral etoposide,
This is the first report of biopsy-proven pulmonary toxicity associate
d with this agent.